XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income $ 22,331 $ (17,801)
Adjustments to reconcile net (loss)/income to net cash provided by operating activities:    
Stock-based compensation 5,539 5,686
Depreciation and amortization 4,028 4,996
Loss on disposal of fixed assets 222 53
Impairment of intangibles (8,713) 9,518
Impairment of lease right-of-use asset and store fixed assets 612 28,821
Deferred taxes 206 (8,338)
Accrued interest on note receivable - related party (6) (8)
Change in valuation of contingent considerations 470 0
Recovery of receivables, related to the Payless ShoeSource bankruptcy (919) 0
Changes, net of acquisitions, in:    
Accounts receivable (8,759) 8,023
Factor accounts receivable (32,491) (14,937)
Notes receivable - related party 102 102
Inventories (5,141) 34,631
Prepaid expenses, prepaid taxes, deposits and other (3,319) (8,000)
Accounts payable and accrued expenses 22,097 (71,108)
Accrued incentive compensation (112) (8,821)
Leases and other liabilities 182 (2,426)
Net cash provided by/(used in) operating activities 5,042 (39,609)
Cash flows from investing activities:    
Capital expenditures (1,598) (3,301)
Purchases of short-term investments (2,054) (5,542)
Maturity/sale of short-term investments 2,036 8,616
Net cash (used in) investing activities (1,616) (227)
Cash flows from financing activities:    
Tax benefit from the exercise of options 1,554 874
Distribution of noncontrolling interest earnings (1,363) 0
Common stock purchased for treasury (5,558) (29,139)
Cash dividends paid on common stock (12,425) (12,459)
Advances from factor 0 42,539
Repayments of advances from factor 0 (13,439)
Net cash (used in) financing activities (17,792) (11,624)
Effect of Exchange Rate on Cash and Cash Equivalents (296) (1,503)
Net (decrease) in cash and cash equivalents (14,662) (52,963)
Cash and cash equivalents – beginning of period 247,864 264,101
Cash and cash equivalents – end of period $ 233,202 $ 211,138